Lunning and Nastoupil Highlight Treatment Considerations and Ongoing Research in Follicular Lymphoma

The Blood Club, hosted by Matthew Lunning, DO, FACP, is a podcast that seeks to translate the latest hematologic oncology research findings into practical clinical implications for the treatment of patients with hematologic malignancies. Dr Lunning is an associate professor in the Division of Oncology & Hematology, associate vice chair of research in the Department of Internal Medicine, and assistant vice chancellor of clinical research at the University of Nebraska Medical Center in Omaha.

In this episode, Dr Lunning sits down with Loretta J. Nastoupil, MD, to discuss treatment considerations for patients with follicular lymphoma (FL). Dr Nastoupil is an associate professor, director of the Lymphoma Outcomes Database, and section chief of New Drug Development in the Department of Lymphoma/Myeloma in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston.

Drs Lunning and Nastoupil discussed the ins and outs of diagnostic workups for patients with FL; how to discern which patients may benefit most from standard chemotherapy vs clinical trial regimens in the frontline setting; and ongoing FL research that may alter the treatment paradigm.